Loading…
Azenta, Inc. is projected to rise to $37.09 by 2027, a +32% move from its current price of $28.13. AZTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $27.48 | $28.13 | $28.81 | +0.01% |
| Aug 3 | $27.21 | $28.14 | $29.10 | +0.03% |
| Aug 4 | $27.01 | $28.14 | $29.32 | +0.04% |
| Aug 5 | $26.84 | $28.15 | $29.51 | +0.05% |
| Aug 6 | $26.70 | $28.15 | $29.68 | +0.07% |
| Aug 7 | $26.57 | $28.15 | $29.83 | +0.08% |
| Aug 8 | $26.45 | $28.16 | $29.98 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.45 | $28.16 | $29.98 | +0.10% |
| Week 2 | $25.80 | $28.18 | $30.79 | +0.19% |
| Week 3 | $25.31 | $28.21 | $31.44 | +0.29% |
| Week 4 | $24.91 | $28.24 | $32.01 | +0.38% |
| Week 5 | $24.57 | $28.26 | $32.51 | +0.48% |
| Week 6 | $24.27 | $28.29 | $32.98 | +0.58% |
| Week 7 | $23.99 | $28.32 | $33.42 | +0.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Azenta, Inc. is a healthcare company that provides biological and chemical sample exploration and management solutions for the life sciences industry. It operates through the Sample Management Solutions and Multiomics segments, serving clients in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
The Sample Management Solutions segment offers automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services and consultation throughout experimental design and implementation. The Multiomics segment provides genomic and other sample analysis services including gene sequencing, gene synthesis, and related services.
Azenta was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. The company was founded in 1978 and is headquartered in Burlington, Massachusetts. It also has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space.
Azenta, Inc. (AZTA) trades with a current price of $28.93 and a market cap of $1.33B, ranking 2251. The stock sits in a healthcare niche focused on life sciences sample management and genomic analysis. The long-range forecast implies meaningful upside, with yearly averages moving higher from 2026 through 2050.
For 2030, the avg price is projected at $70.60 with an ROI of 144 and a bullish sentiment. By 2040, the avg price is forecast at $211.93 with an ROI of 632.5, and by 2050 the avg price is forecast at $426.15 with an ROI of 1373, suggesting substantial long-term upside.
A major floor 43.1% below — a decisive break under it would weaken the trend.
The nearest floor, 21.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.8% away) — a breakout level to watch.
A major ceiling 17.8% above — clearing it would confirm fresh momentum.
Key AZTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AZTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $28.33 | Sell | $28.22 | Sell |
| MA 10 | $27.73 | Buy | $27.78 | Buy |
| MA 20 | $26.75 | Buy | $26.90 | Buy |
| MA 50 | $24.46 | Buy | $25.28 | Buy |
| MA 100 | $23.17 | Buy | $25.24 | Buy |
| MA 200 | $28.04 | Buy | $27.24 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.16 | Neutral |
| Stoch RSI (14) | 20.97 | Neutral |
| CCI (20) | 87.42 | Neutral |
| Williams %R (14) | -22.92 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 5.32 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 77.08 | Neutral |
| TRIX (15) | 0.64 | Buy |
| Awesome (5,34) | 2.71 | Buy |
| Ultimate (7,14,28) | 61.01 | Neutral |
| Momentum (10) | 1.84 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 28.79 | Sell |
| ADX (14) | 26.45 | Buy |
| ATR (14) | 0.61 | Info |
The 30-day technical picture is bullish with RSI(14) at 70. The stock is trading around the SMA50 of $23.75 and the SMA200 of $28.08, with resistance listed at $28.93 and support at $22.20.
The 30-day range spans $24.59 to $34.04, illustrating recent volatility within a bullish context. These near-term indicators point to continued strength but note the elevated short-term activity around the current price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.02 | $28.13 | $36.17 | 0% | Neutral | |
| $29.94 | $37.09 | $48.35 | +32% | Bullish | |
| $36.23 | $45.98 | $61.96 | +63% | Bullish | |
| $44.05 | $57.03 | $78.88 | +103% | Bullish | |
| $51.96 | $68.46 | $96.77 | +143% | Bullish | |
| $54.46 | $72.89 | $105.01 | +159% | Bullish | |
| $60.33 | $81.94 | $120.09 | +191% | Bullish | |
| $67.11 | $92.40 | $137.55 | +228% | Bullish | |
| $75.91 | $105.89 | $159.89 | +276% | Bullish | |
| $96.14 | $135.78 | $207.77 | +383% | Bullish | |
| $138.05 | $206.17 | $333.59 | +633% | Bullish | |
| $252.60 | $414.64 | $728.15 | +13.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $16.02 | $28.13 | $33.67 | +0.00% |
| September 2026 | $24.41 | $28.77 | $34.79 | +2.28% |
| October 2026 | $24.03 | $28.48 | $34.76 | -1.00% |
| November 2026 | $23.64 | $28.16 | $34.62 | -1.14% |
| December 2026 | $24.42 | $29.22 | $36.17 | +3.77% |
Click any year to see its month-by-month AZTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The AZTA price prediction for 2026 points to an average of $28.13 (low $16.02, high $36.17) — a potential gain of 0% on today's $28.13. A consolidation phase looks the most probable path here.
In 2027, AZTA is projected to trade between $29.94 and $48.35, averaging $37.09 — a potential gain of +32% from today's $28.13. That is up +32% on the projected 2026 average. Momentum favours further upside here.
Azenta, Inc.'s 2028 outlook centres on $45.98, within a $36.23 to $61.96 range. That is up +24% on the projected 2027 average. That marks a +63% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, AZTA could reach as high as $78.88, with a base case around $57.03 and support toward $44.05 — roughly +103% from $28.13. Momentum favours further upside here.
Expect AZTA to range from $51.96 to $96.77 through 2030. The $68.46 average target implies a +143% move from current prices. That is up +20% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The AZTA price prediction for 2031 points to an average of $72.89 (low $54.46, high $105.01) — a potential gain of +159% on today's $28.13. Momentum favours further upside here.
In 2032, AZTA is projected to trade between $60.33 and $120.09, averaging $81.94 — a potential gain of +191% from today's $28.13. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Azenta, Inc.'s 2033 outlook centres on $92.40, within a $67.11 to $137.55 range. That is up +13% on the projected 2032 average. That marks a +228% change versus current levels. Momentum favours further upside here.
By 2034, AZTA could reach as high as $159.89, with a base case around $105.89 and support toward $75.91 — roughly +276% from $28.13. Buyers look set to stay in control over this stretch.
Expect AZTA to range from $96.14 to $207.77 through 2035. The $135.78 average target implies a +383% move from current prices. That is up +28% on the projected 2034 average. Momentum favours further upside here.
The AZTA price prediction for 2040 points to an average of $206.17 (low $138.05, high $333.59) — a potential gain of +633% on today's $28.13. Buyers look set to stay in control over this stretch.
In 2050, AZTA is projected to trade between $252.60 and $728.15, averaging $414.64 — a potential gain of +13.7x from today's $28.13. That is up +101% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in AZTA today (≈ 35.549236 AZTA) could be worth
$14,740.15
+$13,740.15 (+1374%) by 2050 · US Dollar
Based on the average projected AZTA price of $414.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AZTAwould be worth at today's price.
$1,000 invested in AZTA on Jul 31, 2025 (≈ 30.581039 AZTA) would be worth
$860.24
-$139.76 (-14.0%) today · 0.86× · US Dollar
Based on a AZTA entry price of $32.7 vs. today's $28.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.37 | $1,027.77 | +2.8% |
| 1 month ago | $26.19 | $1,074.07 | +7.4% |
| 3 months ago | $24.91 | $1,129.27 | +12.9% |
| 6 months ago | $37.53 | $749.53 | -25.0% |
| 1 year ago | $32.7 | $860.24 | -14.0% |
| All time (5.0y) ago | $87.87 | $320.13 | -68.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AZTA forecast.
Our base-case forecast reaches $56.00 around 2029.
Implied market cap at $56.00: $2.58B
The multi-year forecast outlines a steady, bullish trajectory, with 2027 avg $38.11 and ROI 31.7, 2028 avg $47.40 and ROI 63.8, 2029 avg $58.97 and ROI 103.8, and 2030 avg $70.60 with ROI 144. The path then extends to 2031 avg $75.03 (ROI 159.3) and 2032 avg $84.30 (ROI 191.4), culminating in 2035 avg $140.60 (ROI 386). Beyond 2035, the forecast shows even larger gains, with 2040 avg $211.93 (ROI 632.5) and 2050 avg $426.15 (ROI 1373).
Overall, the outlook is bullish across the long horizon, with steadily rising averages and increasingly large ROI, driven by expanding market demand in life sciences sample management and multiomics services. These figures are estimates, not guarantees, and are subject to market volatility and other risks.
Tap a question to reveal the answer.
2030 min $53.25, avg $70.60, max $100.56; ROI 144; sentiment BULLISH.
The forecasts show bullish sentiment across years, with rising averages: 2027 avg $38.11 (ROI 31.7), 2028 avg $47.40 (ROI 63.8), 2029 avg $58.97 (ROI 103.8), 2030 avg $70.60 (ROI 144), 2040 avg $211.93 (ROI 632.5), and 2050 avg $426.15 (ROI 1373). These are estimates, not guarantees.
Yes. The 2030 max is $100.56; longer horizons show higher ceilings, with 2040 max $347.01 and 2050 max $759.06.
The near term centers on 2026 with avg price $28.93 (current price $28.93) and a 30-day range of $24.59-$34.04; RSI(14) is 70, SMA50 is $23.75, SMA200 is $28.08, with support at $22.20 and resistance at $28.93.
Current price is $28.93 with a market cap of $1.33B and a rank of 2251.
Azenta, Inc. Community Discussion
0Share your Azenta, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.